I agree that this is critical, and Bio-Amber's reported progress is very pleasant news indeed given the backdrop of failure and alleged fraud at some other operations, which Lane has documented very clearly over the last number of years. But I would argue there are a couple of other factors as well.
Monday, September 5, 2016
Moving new processes to full scale: Plenty of pitfalls
Jim Lane runs one of the best known blogs in the field of bio-products, and in his latest post (here), he uses BioAmber's recently announced successes to identify critical drivers for success when scaling up a novel bio-based process. He concludes that the operating culture of the company is critical, and that many technology developers are ill-equipped to be owner-operators.
I agree that this is critical, and Bio-Amber's reported progress is very pleasant news indeed given the backdrop of failure and alleged fraud at some other operations, which Lane has documented very clearly over the last number of years. But I would argue there are a couple of other factors as well.
I agree that this is critical, and Bio-Amber's reported progress is very pleasant news indeed given the backdrop of failure and alleged fraud at some other operations, which Lane has documented very clearly over the last number of years. But I would argue there are a couple of other factors as well.
Subscribe to:
Posts (Atom)